Lab Interpretation
Gut Bacteria Markers on the Organic Acids Test: A Practitioner's Interpretation Guide
When a patient comes in with brain fog, anxiety, and chronic bloating after years of antibiotic use, it's tempting to go straight to a stool test. But the...
Gut Bacteria Markers on the Organic Acids Test: A Practitioner's Interpretation Guide
→ Pillar: Organic Acids Test | Hub: Lab Interpretation
When a patient comes in with brain fog, anxiety, and chronic bloating after years of antibiotic use, it's tempting to go straight to a stool test. But the Organic Acids Test (OAT) often tells you something the stool test can't: what the microbes are actually doing metabolically, and how those activities are affecting your patient systemically.
The gut bacteria and yeast markers on the OAT are one of the most clinically useful — and most commonly misread — sections of the panel. Here's how to interpret them correctly.
What are the gut bacteria markers on the Organic Acids Test?
The OAT doesn't identify microorganisms directly. Instead, it measures microbial metabolites — biochemical byproducts of bacterial and fungal activity that are excreted in the urine. This is a fundamentally different approach from stool testing, and it matters for interpretation.
The gut microbial markers on the OAT fall into three categories:
- Yeast/fungal markers — primarily Candida fermentation byproducts
- Clostridia markers — metabolites from specific anaerobic bacterial species
- General dysbiosis markers — phenolic compounds from broad bacterial amino acid fermentation
Each category tells a different part of the story. Interpreting one in isolation — especially if just one or two markers are mildly elevated — reduces clinical utility. Pattern recognition across the section is more reliable than flagging a single outlier.
What do yeast markers on the OAT mean?
Arabinose is the headline yeast marker on the OAT, and it earns that status. It's a well-characterized fermentation byproduct of Candida species, particularly C. albicans, and its elevation in urine is a recognized indirect indicator of intestinal candidiasis. Shaw et al. established arabinose and tartaric acid as fungal metabolite markers in a landmark 1995 paper identifying abnormal organic acid patterns in patients with autistic features and suspected yeast overgrowth.¹ Subsequent research confirmed the D-arabinitol/L-arabinitol ratio in urine as a reliable Candida biomarker.²
Tartaric acid is the other primary yeast marker. When elevated alongside arabinose, it strengthens the Candida signal. Tartaric acid can also interfere with Krebs cycle function at high levels — it competitively inhibits fumarase — which may explain why some patients with active yeast overgrowth show secondary elevations in citric acid cycle intermediates.
Other fungal markers worth noting:
- Citric acid: Often secondarily elevated in yeast overgrowth — Candida produces citric acid as a fermentation byproduct, so high levels without an obvious dietary or metabolic cause should prompt scrutiny of the yeast section
- 5-Hydroxymethyl-2-furoic acid: A less-studied fungal metabolite; when elevated alongside arabinose and tartaric acid, it supports a consistent fungal picture
Limitations to communicate to colleagues: Arabinose has dietary sources — it's present in certain fruits and plant foods. An isolated borderline elevation in an asymptomatic patient with no other supporting markers warrants clinical correlation, not automatic antifungal treatment. High-arabinose foods (pears, apples, grape juice) consumed the day before collection can transiently elevate the result.
When the yeast markers are telling a real story, the patient usually has it: bloating, sugar cravings, recurrent yeast infections, fatigue that worsens after meals, and brain fog. The lab confirms what the history already suggests.
What are the Clostridia markers on the OAT, and why do they matter for neurotransmitter balance?
This is the section of the OAT that surprises most practitioners the first time they see it clearly.
HPHPA (3-(3-hydroxyphenyl)-3-hydroxypropionic acid) is produced by anaerobic Clostridia species — primarily C. sporogenes, C. caloritolerans, and C. botulinum. It's the most clinically significant Clostridia marker on the OAT, and its mechanism of action explains why patients with Clostridia overgrowth often present with neuropsychiatric symptoms rather than purely GI complaints.
HPHPA inhibits dopamine-beta-hydroxylase (DBH), the enzyme responsible for converting dopamine into norepinephrine. When DBH is blocked, dopamine accumulates and norepinephrine drops.³ The downstream effects are measurable on the OAT itself: the HVA:VMA ratio (homovanillic acid to vanillylmandelic acid) rises when this pathway is disrupted — HVA is the dopamine metabolite, VMA is the norepinephrine metabolite. A high HVA:VMA ratio in the context of elevated HPHPA is a fairly compelling signal that dopamine-norepinephrine conversion is impaired.
4-Cresol is co-produced alongside HPHPA by the same Clostridia species and has a similar DBH-inhibiting mechanism.⁴ Elevations of both HPHPA and 4-cresol together create a more potent disruption of neurotransmitter balance. The clinical research here comes disproportionately from pediatric autism literature — HPHPA and 4-cresol elevations have been documented in autism spectrum disorder and behavioral dysregulation — but the mechanism is not pediatric-specific. I've seen this pattern in adult patients presenting with anxiety, OCD-like rumination, irritability, and unexplained fatigue.
3-Indoleacetic acid is the least commonly elevated of the Clostridia markers. It's produced via bacterial tryptophan metabolism and, when elevated alongside HPHPA and 4-cresol, rounds out a picture of significant anaerobic dysbiosis.
Treatment evidence: Oral vancomycin has demonstrated marked reduction in urinary HPHPA, 3-HPA, and 3-HHA levels, providing both a mechanistic confirmation (the bacteria are the source) and a treatment pathway.⁵ In functional medicine practice, more commonly used are antimicrobial herbs — berberine, oregano oil, and allicin — combined with Saccharomyces boulardii, which has demonstrated activity against Clostridia through competitive inhibition and intestinal barrier support.
Clinical pearl: When a patient presents with anxiety, mood dysregulation, or OCD-like symptoms and the standard psychiatric workup is unremarkable, check the OAT Clostridia markers. The gut-brain connection here isn't metaphorical — it's biochemical and traceable.
[DIAGRAM: How Clostridia HPHPA Disrupts Neurotransmitter Balance] Pathway diagram: Tyrosine → Dopamine → [DBH blocked by HPHPA/4-cresol from Clostridia] → ↓Norepinephrine. Clinical infographic style, muted blue/grey tones. Labels: Dopamine, Dopamine-Beta-Hydroxylase, HPHPA (Clostridia), Norepinephrine (blocked). Clean, minimal.
What are OAT dysbiosis markers, and how do I interpret the phenolic compound section?
The general dysbiosis markers on the OAT are products of bacterial fermentation of aromatic amino acids — phenylalanine, tyrosine, and tryptophan — in the gut. Elevated levels signal that bacteria are metabolically active in environments where they're producing these compounds in excess, typically the small intestine or a dysbiotic large bowel.
Key markers and their interpretation:⁶
| Marker | Primary Pathway | Clinical Significance |
|---|---|---|
| Phenylpropionate | Phenylalanine fermentation by bacteria | Elevated with SIBO and broad bacterial dysbiosis |
| Phenylacetate | Phenylalanine/tyrosine bacterial catabolism | Co-elevates with phenylpropionate; general overgrowth signal |
| Hippurate | Glycine conjugation of benzoate (bacterial) | Reflects both microbial load and glycine conjugation capacity |
| Benzoate | Bacterial phenylalanine fermentation | Precursor to hippurate; may indicate glycine depletion if hippurate is low despite high benzoate |
| Indican | Tryptophan fermentation → indole → indican | Classic SIBO marker; strongly elevated with bacterial overgrowth |
| D-Lactate | Produced by Lactobacillus/Bifidobacterium species | Elevated with certain overgrowth states; associated with D-lactic acidosis in severe cases |
Pattern recognition matters here. A single mildly elevated phenolic compound is not clinically actionable on its own. When multiple phenolic markers are elevated together — say, phenylpropionate, hippurate, and indican simultaneously — that pattern signals broad bacterial dysbiosis even when no single marker is dramatically out of range. Think of it as a constellation rather than a single star.
How is the OAT different from stool testing for gut bacteria?
They're complementary, and you need to understand the distinction to use each appropriately.
Stool testing (GI-MAP, Comprehensive Stool Analysis) tells you who's there: direct identification of organisms by PCR or culture, with quantitation. It gives you a local snapshot of the gut environment — who's colonized, in what numbers, and whether pathogenic species are detected.
OAT gut markers tell you what they're doing systemically: the metabolic byproducts circulating in the body after gut microbes produce them and they're absorbed and excreted renally. This gives you a functional, systemic picture. A patient can have moderate Clostridia on stool testing with relatively few symptoms, but if HPHPA is significantly elevated on the OAT, those Clostridia are metabolically active and producing enough DBH-inhibiting metabolites to affect neurotransmitter balance.
The practical workflow: OAT microbial markers generate the hypothesis; stool testing confirms the organism. If HPHPA is elevated on OAT, use that to drive targeted stool testing or empirical antimicrobial treatment. If arabinose is elevated, GI-MAP can confirm Candida presence. Neither test alone gives the complete picture.
[DIAGRAM: OAT vs Stool Testing — What Each Reveals About Gut Microbes] Two-column comparison infographic: OAT (urine metabolites, functional markers, systemic reach) vs Stool Test (direct organism identification, local gut environment, quantitative counts). Medical infographic, clean sans-serif, light background.
Case Example: Yeast + Clostridia Co-Occurrence After Antibiotic Use
Patient: 34-year-old female. Two-year history of brain fog, anxiety, sugar cravings, bloating, and recurrent vaginal yeast infections. Three to four antibiotic courses in the prior three years for recurrent UTIs.
OAT Microbial Findings:
- Arabinose: 3× upper limit of normal
- Tartaric acid: Elevated
- HPHPA: Elevated
- 4-Cresol: Borderline elevated
- HVA:VMA ratio: Elevated (consistent with DBH inhibition)
- Phenylpropionate: Mildly elevated
Interpretation: Active yeast overgrowth (likely Candida) with concurrent Clostridia overgrowth. The elevated HVA:VMA ratio alongside HPHPA was the connecting piece that explained her anxiety — the Clostridia were biochemically disrupting her dopamine-to-norepinephrine conversion. Prior antibiotic exposure had likely eliminated colonization resistance, creating conditions for both yeast and Clostridia to thrive simultaneously. The mildly elevated phenylpropionate added a background signal of general bacterial dysbiosis.
Protocol:
- Weeks 1–4 (Antifungal phase): Low-sugar diet; berberine 500mg TID; oregano oil 200mg BID; Saccharomyces boulardii 10B CFU daily (active against both Candida and Clostridia)
- Weeks 1–8 (Clostridia support): Continued S. boulardii throughout; antimicrobial herbs; monitored symptoms weekly
- Week 5 onward (Recolonization): Introduced multi-strain Lactobacillus/Bifidobacterium probiotic blend
- Gut repair: L-glutamine 5g daily, collagen peptides, zinc carnosine 75mg daily
- Retest: OAT at 3 months
Outcome: Arabinose normalized. HPHPA reduced significantly. Patient reported approximately 70% improvement in brain fog and anxiety by week 8. This pattern — antibiotic history, dual yeast/Clostridia signal, neuropsychiatric symptoms explained by the Clostridia mechanism — is one I've seen consistently across this patient profile.
(De-identified composite case based on pattern from functional medicine practice. Clinical framework adapted from Peter Kozlowski, MD protocols.)
How do I treat elevated OAT gut bacteria markers?
Match the intervention to the marker type:
Elevated yeast markers (arabinose, tartaric acid):
- Low-sugar, low-refined-carbohydrate diet during treatment phase
- Herbal antifungals: berberine 500mg TID, oregano oil, garlic/allicin
- Saccharomyces boulardii — well-supported for Candida and intestinal barrier restoration
- Retest at 3 months; arabinose normalizes relatively quickly with treatment
Elevated Clostridia markers (HPHPA, 4-cresol):
- Targeted antimicrobials: S. boulardii first-line; antimicrobial herbs (berberine, oregano)
- Severe or refractory cases: oral vancomycin demonstrates significant urinary HPHPA reduction; this is an option worth discussing with patients in cases of marked elevation with significant neuropsychiatric burden
- Recolonization after treatment phase is critical — Clostridia fill vacuums
- Address contributing factors: proton pump inhibitor use, fiber intake, motility
General dysbiosis markers (phenolic compounds, indican):
- Broader gut reset using 5R framework (Remove, Replace, Reinoculate, Repair, Rebalance)
- If indican is significantly elevated, consider breath testing to rule out SIBO → SIBO Treatment Protocols
- Increase dietary fiber diversity to support competitive microbiome recovery
Universal principle: OAT microbial markers are functional signals, not diagnoses. No single marker is definitive, and no intervention decision should rest on the OAT alone. The OAT tells you where to look — clinical judgment and ideally confirmatory testing (stool, breath) tell you what to do.
Practical Takeaways
Arabinose is your primary yeast signal — elevated arabinose with supporting symptoms and other fungal markers is a reliable Candida indicator; isolated mild elevation in an asymptomatic patient needs context
HPHPA is the most clinically important Clostridia marker — elevated HPHPA with a high HVA:VMA ratio is a mechanistic explanation for anxiety and mood dysregulation that many patients have never received
The OAT measures what microbes are doing, not who they are — use it to generate hypotheses and guide stool testing, not as a standalone diagnostic
Cluster elevation matters more than single-marker elevation — multiple phenolic markers elevated together signal broader dysbiosis even if each individual value is only mildly high
Antibiotic history changes the risk profile — patients with significant antibiotic exposure deserve closer scrutiny of the OAT microbial section regardless of other flags
Retest at 3–6 months — OAT microbial markers respond to intervention; documenting improvement validates the protocol and closes the clinical loop
References
Shaw WR, Adams JB, Kleiber ML. "Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features." Clin Chem. 1995;41(8):1094–1104. PMID: 7628083
Kader IA, Allsopp J, Tan-Kung-Lum L, et al. "Urine D-arabinitol/L-arabinitol ratio in diagnosing invasive candidiasis." J Infect. 2002;44(1):31–36. PMID: 11821170
Shaw W. "Inhibition of the Beta-oxidation Pathway of Fatty Acids and Dopamine-Beta-hydroxylase by Phenyl Derivatives of Short-Chain Fatty Acids from Gastrointestinal Clostridia Bacteria." J Orthomolecular Med. 2023. PMID: 37363147
Shaw W. "Inhibition of dopamine conversion to norepinephrine by Clostridia metabolites 4-cresol and HPHPA." PMC Full Text. 2023. PMC10289112
Lord RS, Bralley JA. "Clinical applications of urinary organic acids. Part 2. Dysbiosis markers." Altern Med Rev. 2008;13(4):292–306. PMID: 19152477
Related Articles
- OAT Mitochondrial Function Markers Explained →
- Oxalates and Detoxification on OAT → (forthcoming)
- Reading Your GI-MAP Results →
- GI-MAP Dysbiosis Treatment Protocols →
- SIBO Treatment Protocols →
- Leaky Gut Syndrome Treatment →
Ready to Spend Less Time on OAT Documentation?
Interpreting an OAT takes clinical depth. Documenting it — every marker, every pattern, every follow-up note — takes time you don't have.
HANS automates functional medicine documentation so you can interpret and act, not type. OAT results, GI-MAP findings, DUTCH panels — structured into your notes in seconds.